Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 204
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
Introducing The Psychedelic News Feed Podcast
PT296 – Dr. David Luke – Vital Psychedelic Conversations
Reclaiming Ownership of Your Body With Psychedelics
Tackling Trauma with Pharmahuasca and DMT
World’s First Clinical Trial for DMT-Assisted Therapy in Major Depressive Disorder...
PT295 – Sidarta Ribeiro – Dreams, LSD, and Biopiracy
Psychedelic Bulletin: Tracking LSD Patents; Psilocybin Effective for a Year in...
PT294 – Andrew Tatarsky, Ph.D. & Juliana Mulligan – Vital Psychedelic...
HAVN Life Enters into Distribution Agreement with Mycrodose Therapeutics for U.S....
Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access...
Trauma and Vulnerability to Suggestion: Redefining How We Understand Consent
Load more